I find it improbable that Dr. BP would not conduct complete cytokine, RNA transcriptions, etc on severe/ critical patients. This was offered free for MIS-C /Kawasaki like disease manifestations in pediatric patients.

Dr BP and Incelldx appear to be glued at the hip to Cytodyn. I expect that he and his company will (appropriately) provide any analysis needed to keep this process moving forward.

The waiting is painful. I can only imagine how this must be for the longtime holders from the Pro 140 early HIV trial days.

As many others have said, be patient. Support cytodyn as they navigate the approval process and progression from a clinical stage company to a commercial stage one.

For those who have not voted, please support the issuance of new share. This protects us from a takeover by big pharm and give the company the resources to make this drug available to the world.

While most of us are focused on Covid in the short term, many millions will benefit in HIV, NASH, multiple solid tumor cancers and potentially Parkinsons among others.

Let us not impede by short sighted decisions the opportunity that this presents to impact untold numbers of lives.

Shareholders will see fantasied realized. It will just take a bit longer than we would like. Stay safe everyone.